Nancy Kelley is the CEO of Kyttaro Therapeutics. Previously she was Founding Executive Director of the New York Genome Center and architected the launch of OmniSeq, now part of Labcorp Oncology. Ms Kelly is also Co-Founder of Builds Bio+, Co-Founder of the Center of Excellence for Engineering Biology. She holds JD/MPP degrees from Harvard Law School/ Kennedy School and a BA from Yale University.